Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 7, October, p. 1047–1051

doi: 10.17219/acem/64939

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The angiotensin II receptors type 1 blockage affects the urinary bladder activity in hyperosmolar-induced detrusor overactivity in rats: Preliminary results

Kajetan Juszczak1,2,A,B,C,D,E,F, Piotr Maciukiewicz2,A,E,F

1 Department of Pathophysiology, Jagiellonian University Medical College, Kraków, Poland

2 Department of Urology, Memorial Rydygier Hospital, Kraków, Poland

Abstract

Background. Angiotensin II receptors play a role in the pathogenesis of urinary bladder dysfunction, especially in the case of bladder outlet obstruction. The function of these receptors in the detrusor overactivity (DO) still remains unclear.
Objectives. The study aims to investigate some of the mechanisms through which hyperosmolarity induces urinary bladder overactivity. The effect of angiotensin II receptor type 1 – AT1 (telmisartan) on urinary bladder function in physiological state and in hyperosmolar-induced DO in rat model was explored.
Material and Methods. Experiments were performed on 32 female Wistar rats. DO was induced by hyperosmolar saline intravesical instillation. Surgical procedures and cystometry were performed under urethane anesthesia. The measurements represent the average of 5 bladder micturition cycles. We analyzed: basal pressure, threshold pressure, micturition voiding pressure, intercontraction interval, compliance, functional bladder capacity, motility index and detrusor overactivity index.
Results. Intravesical hyperosmolar saline instillation induced DO. Telmisartan diminished the severity of hyperosmolar-induced DO. We observed a statistically significant increase of intercontraction interval (55%), functional bladder capacity (54%), compliance (140%). Also, a statistically significant decrease of detrusor overactivity index (18%) and motility index (9%) were observed. The difference of basal pressure, threshold pressure and micturition voiding pressure were not statistically significant. Moreover, telmisartan has no effect on urodynamic parameters in naïve rats.
Conclusion. Detrusor overactivity due to intravesical increased osmolarity seems to be at least partially mediated by AT1 receptors activity. On one hand, telmisartan diminished the severity of hyperosmolarinduced DO, and, on the other hand, has no effect on urodynamic parameters in naïve rats.

Key words

rat, overactive bladder, telmisartan, osmolarity, cystometry

References (20)

  1. Hoyle CH. Non-adrenergic, non-cholinergic control of the urinary bladder. World J Urol. 1994;12:233–244.
  2. Phull H, Salkini M, Escobar C, Purves T, Comiter CV. The role of angiotensin II in stress urinary incontinence: A rat model. Neurourol Urodyn. 2007;26:81–88.
  3. Tanabe N, Ueno A, Tsujimoto G. Angiotensin II receptors in the rat urinary bladder smooth muscle: Type 1 subtype receptors mediate contractile responses. J Urol. 1993;150:1056–1059.
  4. Ramos-Filho AC, A Faria J, Calmasini FB, et al. The renin-angiotensin system plays a major role in voiding dysfunction of ovariectomized rats. Life Sci. 2013;93:820–829.
  5. Cho ST, Park EZ, Kim JC. Effect of angiotensin II receptor antagonist telmisartan on detrusor overactivity in rats with bladder outlet obstruction. Urology. 2012;80(5):1163.e1–7.
  6. Dinis P, Churrua A, Avelino A, Cruz F. Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU Int. 2004;94:153–157.
  7. Garland A, Jordan JE, Necheles J, et al. Hypertonicity, but not hypothermia, elicits substance P release from rat C-fiber neurons in primary culture. J Clin Invest. 1995;95:2359–2366.
  8. Kulick LJ, Clemons DJ, Hall R, Koch MA. Refinement of the urine concentration test in rats. Contemp Top Lab Anim Sci. 2005;44:46–49.
  9. Juszczak K, Ziomber A, Wyczółkowski M, Thor PJ. Hyperosmolarity alters the micturition: The comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder. Can J Physiol Pharmacol. 2010;88:899–906.
  10. Juszczak K, Ziomber A, Wyczółkowski M, Thor PJ. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic overactive bladder model rats. J Physiol Pharmacol. 2009;60,:85–91.
  11. Juszczak K, Krolczyk G, Filipek M, Dobrowolski ZF, Thor PJ. Animal models of overactive bladder: Cyclophosphamide (CYP)-induced cystitis in rats. Folia Med Cracov. 2007;48:113–123.
  12. Ito H, Taga M, Tsuchiyama K, Akino H, Yokoyama O. IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: Posthoc analyses of a lower urinary tract symptoms population. Neurourol Urodyn. 2013;32:70–74.
  13. Ford CM, Li S, Pickering JG. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol. 1999;19:1843–1851.
  14. Elliott CS, Comiter CV. The effect of angiotensin inhibition on urinary incontinence: Data from the National Health and Nutrition Examination Survey (2001–2008). Neurourol Urodyn. 2014;33:1178–1181.
  15. Saito M, Kondo A, Kato T, Miyake K. Response of the human urinary bladder to angiotensins: A comparison between neurogenic and control bladders. J Urol. 1993;149:408–411.
  16. Cheng EY, Decker RS, Lee C. Role of angiotensin II in bladder smooth muscle growth and function. Adv Exp Med Biol. 1999;462:183–191.
  17. Shimizu S, Saito M, Oiwa H, et al. Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress. Neurourol Urodyn. 2014;33:350–357.
  18. Kosilov K, Loparev S, Iwanowskaya M, Kosilova L. Effectiveness of combined high-dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy. Cent European J Urol. 2014;67:43–48.
  19. Malki M, Mangera A, Reid S, Inman R, Chapple C. What is the feasibility of switching to 200IU onabotulinumtoxin A in patients with detrusor overactivity who have previously received 300IU? Cent European J Urol. 2014;67:35–40.
  20. Persu C, Braschi E, Lavelle J. A reviev of prospective clinical trials for neurogenic bladder: Pharmaceuticals. Cent European J Urol. 2014;67:264–269.
© Wroclaw Medical University